Enhancing mesenchymal stem cell survival and homing capability to improve cell engraftment efficacy for liver diseases

Although mesenchymal stem cell (MSC) transplantation provides an alternative strategy for end-stage liver disease (ESLD), further widespread application of MSC therapy is limited owing to low cell engraftment efficiency. Improving cell engraftment efficiency plays a critical role in enhancing MSC th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Shaoxiong, Yu, Saihua, Liu, Haiyan, Liao, Naishun, Liu, Xiaolong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478247/
https://www.ncbi.nlm.nih.gov/pubmed/37667383
http://dx.doi.org/10.1186/s13287-023-03476-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478247/
https://www.ncbi.nlm.nih.gov/pubmed/37667383
http://dx.doi.org/10.1186/s13287-023-03476-4

Ejemplares similares